Presence of Concurrent <i>TP53</i> Mutations Is Necessary to Predict Poor Outcomes within the <i>SMAD4</i> Mutated Subgroup of Metastatic Colorectal Cancer.

Cancers (Basel) · 2022 · PMC9332822 · PMID 35892903

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While our results showed that patients with SMAD4 mutations had a numerically shorter OS than patients with wild-type SMAD4 , such a difference did not reach statistical significance in our analysis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.